ZURICH (Reuters) – Swiss pharmaceutical company Novartis said on Monday its Certican, an immune system drug also known under the names Afinitor and Votubia, showed positive outcomes in a two-year phase III study in liver transplantation. The study, whi…
SCV Biotech Reports Success in Arthritis Candidate StudySCVNEWS.com“In contrast to immunosuppressive drugs, the neuromodulation therapy in this study used an implantable pulse generator to stimulate the vagus nerve, activating the body's natural …
Immunosuppressant Shows Positive Outcomes at 24 Months in Liver Transplant …Monthly Prescribing ReferenceEnrollment into the tacrolimus withdrawal arm was prematurely halted due to a higher incidence of acute rejection episodes and adverse events lea…
Medgadget.comExclusive Interview with Cibiem, a New Player in Carotid Body ModulationMedgadget.comCibiem is a medical device company focusing on a minimally invasive, catheter-based approach for Carotid Body Modulation (CBM). Currently in its early sta…
'Holy grail' results two years on in small cardiac stem cell heart failure trialBioNewsEight heart attack patients given injections of stem cells harvested from their own hearts all show improvement in their heart function two years after treat…
At the annual American Society of Human Genetics meeting, Kaiser Permanente researchers unveiled some initial results from its study of its combined medical and genetic biobank, reports Science Insider.
WESH OrlandoNavy SEAL meets organ donor's family at Disney raceWESH OrlandoShare · NEXT STORY. Man, 38, killed in Orlando. Text Size: ASmall Text; AMedium Text; ALarge Text. Justin Legg (left) received lungs from organ donor Jarred McKinley …
Orgenesis Enters Into R&D Agreement With The Fraunhofer IGBDailyFinance"We are very excited to support Orgenesis in their development of a very promising new therapy for diabetes that overcomes the problem of donor shortage and removes the ris…
Muskegon Chronicle – MLive.comAmerican Red Cross blood drives in November 2012 for Muskegon, Newaygo …Muskegon Chronicle – MLive.com13, 2012, 10 a.m. to 3:45 p.m., Muskegon Blood Donation Center, 313 W. Webster Ave., Muskegon. Nov. 15, 2012, 1-6:45 p…
Novartis new two-year data with Certican(R) shows positive outcomes at 24 …ReutersCalcineurin inhibitors like tacrolimus are part of the standard immunosuppression regimen after a liver transplant but may contribute to a decline in renal function ove…